Syrris Joins Select Group of R&D 100 Award Winners
News Jul 13, 2012
As the longest established provider of laboratory scale flow chemistry systems, Syrris’ wealth of expertise in research and development - as well as its patented technologies - has propelled the modular Asia product line to the forefront of the flow chemistry market.
Designed by chemists, for chemists, Asia enables an extensive range of chemical reactions, at a wide range of temperatures and pressures, with different levels of automation to suit individual laboratory needs.
The esteemed R&D 100 Awards are a benchmark of excellence, with winners chosen by an independent panel of judges and the editors of R&D Magazine.
This award recognizes the significance of flow chemistry and, in particular, Syrris’ contribution to a technology that is enabling chemists to perform faster, safer and cleaner reactions.
Syrris’ success was achieved by establishing that the Asia flow chemistry system improves upon existing technologies, providing evidence of the system’s benefits, including its modularity and wide range of chemical compatibility, and demonstrating how this technology is proving a useful tool for chemists working in such diverse areas as academia and the pharmaceutical, petrochemical and nanoparticle industries.
Mike Hawes, CEO of Syrris, commented: “We are delighted that the Asia system has been announced as a winner of the 50th Annual R&D Awards, acknowledging the success of this groundbreaking technology, and look forward to attending the presentation ceremony in November.”
Cell Recycling System Offers Therapeutic Entry Point for Rare Disease TreatmentNews
Scientists have demonstrated how an investigational drug works against a rare, fatal genetic disease, Niemann-Pick type C1 (NPC1).READ MORE
Cancer Cells Force Normal Cells to Act Like Viruses, Helping Tumors SpreadNews
Researchers reveal how cancer cells force normal cells to act like viruses – allowing tumors to grow, resist treatment, and spread.READ MORE
Edith Heard Unanimously Selected as Next Director General of EMBLNews
At its 53rd meeting yesterday, EMBL Council selected Edith Heard as the organization’s fifth Director General. Heard’s mandate is scheduled to begin 1 January 2019.READ MORE
Comments | 0 ADD COMMENT
EMBL Conference: European Conference of Life Science Funders and Foundations
Apr 19 - Apr 20, 2018
EMBL Course: Target Engagement in Biology and Drug Discovery
Feb 19 - Feb 23, 2018